Cargando…
Immunomodulation in the critically ill
Immunotherapy in the critically ill is an appealing notion because of the apparent abnormal immune and inflammatory responses seen in so many patients. The administration of a medication that could alter immune responses and decrease mortality in patients with sepsis could represent a ‘magic bullet’...
Autores principales: | Webster, N.R., Galley, H.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Journal of Anaesthesia. Published by Elsevier Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543369/ https://www.ncbi.nlm.nih.gov/pubmed/19474216 http://dx.doi.org/10.1093/bja/aep128 |
Ejemplares similares
-
Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
por: Sauer, Andrea, et al.
Publicado: (2022) -
Plant Derived Immunomodulators; A Critical Review
por: Swaroop, Akey Krishna, et al.
Publicado: (2022) -
Targeting circulating high mobility group box-1 and histones by extracorporeal blood purification as an immunomodulation strategy against critical illnesses
por: Li, Yupei, et al.
Publicado: (2023) -
Effect of Immune-Enhancing Enteral Nutrition Enriched with or without Beta-Glucan on Immunomodulation in Critically Ill Patients
por: Lee, Jae Gil, et al.
Publicado: (2016) -
Immunomodulators for Asthma
por: Dimov, Vesselin V, et al.
Publicado: (2010)